CBLL – ceribell, inc. (US:NASDAQ)

News

AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
CeriBell (NASDAQ:CBLL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com